opnurasib,jdq443,tislelizumab
Novartis,Beigene
['jdq443', 'lcsm,(-blcsm)']
jdq443 off inhibitor g12c; 27pts; 200mg bid recommended dose. tox profile is looking good. await further data from multiple ongoing studies #asco23 #lcsm 
Consultant Medical Oncologist, UK. Views are hypothesis generating discourse. Post COVID dabbling in garden.